RECKITT Benckiser’s targeted
relief of pain claims are causing a
stir in the industry, after the TGA
released its determination in relation
to complaints over advertising.
The furore started two years ago
when Choice awarded Nurofen a
Shonky Award for its range of
caplets for migraine, back, tension
headache and period pain whose
ingredients were identical from
product to product.
“So does the back pain version
somehow magically go straight to
your back – and only your back
– as soon as you’ve swallowed it?,”
This award was ...
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 09 Aug 12
Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country. MORE